Oleandomycin
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
|
(3R,5R,6S,7R,8R,11R,12S,13R,14S,15S)-14-((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)-6-hydroxy-12-((2R,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyltetrahydro-2H-pyran-2-yloxy)-5,7,8,11,13,15-hexamethyl-1,9-dioxaspiro[2.13]hexadecane-4,10-dione
|
|
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Identifiers | |
| CAS Number | 3922-90-5 |
| ATC code | J01FA05 |
| PubChem | CID 5284598 |
| ChemSpider | 4447646 |
| UNII | P8ZQ646136 |
| ChEMBL | CHEMBL606258 |
| Chemical data | |
| Formula | C35H61NO12 |
| Molar mass | 687.858 g/mol |
|
|
|
|
| |
Oleandomycin is a macrolide antibiotic. It is synthesized from strains of Streptomyces antibioticus. It is weaker than erythromycin.
It used to be sold under the brand name Sigmamycine, combined with tetracycline, and made by the company Rosa-Phytopharma in France.
|
| This systemic antibacterial-related article is a stub. You can help Wikipedia by expanding it. |

